TDR Trade to Black with Cody Shandraw, the President of the Healing Realty Trust, discusses the next wave of the psychedelic renaissance. Cody has invested in over 50 psychedelic companies, including clinics, drug development, and emerging technologies.

Cody has been looking very closely at the industry and makes his thesis known in this episode about why this might be the time for the next leg up in psychedelic stocks. Cody will also share his thoughts on the upcoming scheduled FDA review for Lykos Therapeutic in August and what may happen to psychedelic stock if approved.

In addition, he looks at catalysts from the large pharmaceutical companies and why these companies are watching the psychedelic space so closely.